Isomerase

Isomerase is a biotechnology research company and service provider specializing in microbial bioengineering. They leverage a proprietary platform, including the IsoZym bioproduction system, to discover and engineer microbes—such as bacteria and fungi—to produce therapeutics, enzymes, and other biomolecules. The company integrates synthetic biology, bioinformatics, and microbial strain development with advanced analytical chemistry and bioprocessing capabilities to optimize production processes. Their technical expertise spans natural product discovery, metabolic engineering, and the development of recombinant peptides, allowing them to provide end-to-end support from early-stage concept and screening through to process scale-up and commercial readiness.

The company serves partners across the pharmaceutical, biotechnology, and sustainability sectors by helping them access difficult chemical spaces and create more cost-effective, sustainable manufacturing routes. By functioning as an innovation partner, Isomerase addresses the challenges of discovering novel compounds or improving existing bioprocesses for complex products like biocatalytic enzymes and natural product analogues. Their work is supported by an extensive, proprietary collection of microbial strains and state-of-the-art laboratory facilities located in the Cambridge Biomedical Cluster. They provide a collaborative model where partners receive dedicated scientific and business points of contact to ensure accountability and project alignment, helping to bridge the gap between initial discovery and industrial-scale application.